Fixed Drug Eruption in a Patient Taking Valacyclovir without Cross-Reactivity to Acyclovir

  • Yeon Gu Choi
  • , Hyeon Jeong Park
  • , Sunmin Yim
  • , Heun Joo Lee
  • , Young Jun Choi
  • , Won Serk Kim
  • , Ga Young Lee

Research output: Contribution to journalArticlepeer-review

Abstract

Fixed drug eruption (FDE) is a well-defined hyperpigmented patch that recurs in a fixed location each time a particular drug is taken. Common causative agents of FDE are non-steroidal anti-inflammatory drugs, non-narcotic analgesics, sedatives, anticonvulsants, sulfonamides, and tetracycline. We report a 33-year-old male who presented with a recurrent, localized, brownish-to-erythematous macule and papules on the peri-philtrum area two hours after taking valacyclovir. Three episodes of valacyclovir ingestion for treatment of Herpes simplex virus infection provoked a similar skin rash at the same site. Histopathology results showed vacuolar degeneration in the basal layer of the epidermis, pigmentary incontinence, and perivascular inflammatory cell infiltration in the papillary dermis. Although patch test and skin prick test showed negative responses to acyclovir and valacyclovir, an intradermal test showed a positive reaction only to valacyclovir. The oral provocation test to acyclovir and valacyclovir showed a positive reaction only to valacyclovir. Through drug history, histopathological examination, patch test, intradermal test, and oral provocation test, we established a final diagnosis of FDE due to valacyclovir without cross-reactivity to acyclovir. To find alternative therapeutic drugs, we suggest diagnostic tests with not only the suspected drugs, but also other drugs in the same class.

Original languageEnglish
Pages (from-to)S55-S58
JournalAnnals of Dermatology
Volume35
DOIs
StatePublished - May 2023
Externally publishedYes

Keywords

  • Acyclovir
  • Cross reactions
  • Drug eruptions
  • Valacyclovir

Fingerprint

Dive into the research topics of 'Fixed Drug Eruption in a Patient Taking Valacyclovir without Cross-Reactivity to Acyclovir'. Together they form a unique fingerprint.

Cite this